Clinical Laboratory Price Transparency Act of 2023

12/20/2024, 9:05 AM
Referred to the Subcommittee on Health.
Bill 118 hr 4882, also known as the Clinical Laboratory Price Transparency Act of 2023, aims to increase transparency in pricing for clinical laboratory services. The bill requires clinical laboratories to provide patients with a clear, itemized list of prices for common tests and procedures before they are performed. This will allow patients to compare prices between different laboratories and make more informed decisions about their healthcare.

Additionally, the bill requires clinical laboratories to disclose any discounts or rebates they receive from insurance companies or other third-party payers. This will help patients understand the true cost of their tests and procedures, and prevent surprise billing.

The Clinical Laboratory Price Transparency Act of 2023 also includes provisions to protect patients from price gouging. It prohibits clinical laboratories from charging unreasonable prices for tests and procedures, and requires them to justify any price increases to a regulatory body. Overall, this bill aims to empower patients to make more informed decisions about their healthcare and protect them from unfair pricing practices in the clinical laboratory industry.
Congress
118

Number
HR - 4882

Introduced on
2023-07-25

# Amendments
0

Sponsors
+5

Variations and Revisions

7/25/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Subcommittee on Health.
Bill 118 hr 4882, also known as the Clinical Laboratory Price Transparency Act of 2023, aims to increase transparency in pricing for clinical laboratory services. The bill requires clinical laboratories to provide patients with a clear, itemized list of prices for common tests and procedures before they are performed. This will allow patients to compare prices between different laboratories and make more informed decisions about their healthcare.

Additionally, the bill requires clinical laboratories to disclose any discounts or rebates they receive from insurance companies or other third-party payers. This will help patients understand the true cost of their tests and procedures, and prevent surprise billing.

The Clinical Laboratory Price Transparency Act of 2023 also includes provisions to protect patients from price gouging. It prohibits clinical laboratories from charging unreasonable prices for tests and procedures, and requires them to justify any price increases to a regulatory body. Overall, this bill aims to empower patients to make more informed decisions about their healthcare and protect them from unfair pricing practices in the clinical laboratory industry.
Alternative Names
Official Title as IntroducedTo amend title XVIII of the Social Security Act to promote laboratory price transparency under the Medicare program.

Policy Areas
Health

Potential Impact
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Internet, web applications, social media
Medical tests and diagnostic methods
Medicare

Comments

Recent Activity

Latest Action12/17/2024
Referred to the Subcommittee on Health.